June 3, 2014 9:30 AM - 5:00 PM
Exploiting research possibility and the huge therapeutic of stem cells necessitates extensive quality-control to ensure the identity, quality, and security of the cell. Stem cells of tissue engineered concepts and their ability to distinguish towards a special phenotype together with different origin are dependent of a variety of procedure including purification methods, biomechanical states and farming media. All matters dealing with investigation and the optimisation of procedures leading to defined in vitro civilized cell lines and designed tissues – with a particular focus on bioreactors – will be discussed in this session. This occasion has CPD certification.
Assembly Chair: Dr Johanna Buschmann, Head of Research Laboratories, University Hospital Zurich, Cosmetic Surgery, Switzerland
Who Should Attend: All these enthusiastic about the use of stem cells for tissue engineered constructs should find this meeting exceptionally precious.
Synopses for poster demonstration just can be submitted up to a couple of weeks before the event. You can download the instructions for authors at:
Dr Marianne Ellis, College of Bath, UK
Development of scalable microcarrier-established tissue engineering
Dr Ivan Wall, Lecturer in Regenerative Medicine Bioprocessing, University College London, UK
Immune Regulation by Mesenchymal Stromal Cells from Umbilical Cord
Dr John Girdlestone, NHS Blood and Graft, UK
Additional confirmed speakers
Professor Athanasios Mantalaris, Imperial College London, UK
Dr Farlan Veraitch, Section of Biochemical Engineering, University College London, UK
Stem Cells and BioProcessing – Taking Place Tuesday, 03 June 2014 09:30 – 17:00
Located at Cineworld: The O2